V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160013224 | 160018850 | 1.67 | 60.5 | Palliative (P) | 2018-01-13 | 2018-01-13 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100688571 |
| 160013230 | 160018851 | 1.6 | 66.5 | Palliative (P) | 2017-07-23 | 2017-07-24 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100316109 |
| 160013244 | 160018852 | 1.83 | 67.4 | null | 2019-08-10 | 2019-08-24 | Trabectedin | 02 | null | TRABECTEDIN | 101799097 |
| 160013256 | 160018853 | 1.62 | 84.1 | Palliative (P) | 2022-01-21 | 2022-01-21 | Doxorubicin 75mg/m2 | 02 | N | TRIAL UNSPECIFIED | 101670964 |
| 160013271 | 160018854 | 1.72 | 76.6 | Palliative (P) | 2018-01-08 | 2018-01-09 | VINORELBINE | 02 | N | VINORELBINE | 101117579 |
| 160013301 | 160018855 | 1.83 | 82.7 | null | 2019-07-08 | 2019-07-21 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101445911 |
| 160013340 | 160018856 | 1.58 | 78.5 | Palliative (P) | 2021-03-24 | 2021-04-02 | VINORELBINE | 02 | N | VINORELBINE | 100897656 |
| 160013359 | 160018857 | 1.81 | 57.7 | null | 2021-03-11 | 2021-03-11 | Doxorubicin 75mg/m2 | 02 | null | VINORELBINE | 101005052 |
| 160013372 | 160018858 | 1.72 | 67.8 | Palliative (P) | 2022-05-02 | 2022-05-02 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101726089 |
| 160013374 | 160018859 | 1.67 | 72.95 | Palliative (P) | null | null | DOXORUBICIN | 02 | N | NIVOLUMAB | 100159492 |
| 160013391 | 160018860 | 1.7 | 75 | Palliative (P) | 2017-09-19 | 2017-09-19 | Doxorubicin 75mg/m2 | 02 | N | NIVOLUMAB | 100657827 |
| 160013402 | 160018861 | 1.91 | 58.8 | Palliative (P) | 2016-12-13 | 2017-04-12 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101472333 |
| 160013408 | 160018862 | 0 | 87 | Palliative (P) | 2022-03-16 | 2022-03-30 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101393182 |
| 160013409 | 160018863 | 1.66 | 61 | null | 2019-11-04 | 2019-11-04 | Vinorelbine (oral) | 02 | null | VINORELBINE | 100716809 |
| 160013414 | 160018864 | 1.9 | 58.4 | Palliative (P) | 2019-04-09 | 2019-04-10 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100000701 |
| 160013453 | 160018865 | 1.77 | 73.7 | Palliative (P) | 2021-06-05 | 2021-07-03 | VINORELBINE | 02 | N | VINORELBINE | 100513473 |
| 160013471 | 160018866 | 1.67 | 83.8 | Palliative (P) | 2021-08-22 | 2021-09-22 | Trabectedin | 02 | N | TRABECTEDIN | 101145327 |
| 160013477 | 160018867 | 1.62 | 70.8 | null | 2020-12-22 | 2021-01-14 | DOXORUBICIN | 02 | null | TRIAL UNSPECIFIED | 100846649 |
| 160013540 | 160018868 | 1.7 | 74.6 | Palliative (P) | null | null | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100878532 |
| 160013573 | 160018869 | 1.73 | 66.4 | Palliative (P) | null | null | Vinorelbine (weekly iv) | 02 | N | VINORELBINE | 100664893 |
| 160013577 | 160018870 | 1.75 | 73.5 | Palliative (P) | 2020-10-26 | 2021-09-17 | DOXORUBICIN | 02 | N | TRABECTEDIN | 100577065 |
| 160013579 | 160018871 | 1.69 | 86.8 | null | 2019-01-07 | 2019-01-15 | DOXORUBICIN | 02 | null | DOXORUBICIN | 101564724 |
| 160013592 | 160018872 | 0 | 51 | null | 2021-01-28 | 2021-03-14 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101039644 |
| 160013594 | 160018873 | 1.77 | 84.5 | Palliative (P) | 2020-04-25 | 2020-09-03 | Trabectedin | 02 | N | TRABECTEDIN | 100606212 |
| 160013612 | 160018874 | 1.11 | 66.3 | null | 2022-01-14 | 2022-01-26 | Vinorelbine (oral) | 02 | null | VINORELBINE | 100317326 |
| 160013616 | 160018875 | 1.42 | 88.2 | null | 2021-07-30 | 2021-07-31 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101318612 |
| 160013630 | 160018876 | 1.63 | 66.8 | null | 2018-02-03 | 2018-03-28 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100239657 |
| 160013636 | 160018877 | 1.88 | 82.8 | Palliative (P) | null | 2018-04-23 | Doxorubicin 75mg/m2 | null | N | TRABECTEDIN | 101104203 |
| 160013660 | 160018878 | 1.73 | 73 | null | 2021-06-07 | 2021-06-16 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100601404 |
| 160013666 | 160018879 | 1.59 | 82.6 | Palliative (P) | null | null | Vinorelbine (oral) | 02 | N | VINORELBINE | 101750850 |
| 160013677 | 160018880 | 1.66 | 85.2 | Palliative (P) | 2020-12-03 | 2020-12-03 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101119609 |
| 160013693 | 160018882 | 1.82 | 103.4 | null | 2018-04-27 | 2018-05-05 | DOXORUBICIN | null | null | VINORELBINE | 101675459 |
| 160013701 | 160018883 | 1.74 | 97 | Palliative (P) | 2018-12-18 | 2019-01-19 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101405344 |
| 160013703 | 160018884 | 1.57 | 51 | Palliative (P) | 2022-04-22 | 2022-05-02 | Doxorubicin 75mg/m2 | null | N | DOXORUBICIN | 101410823 |
| 160013705 | 160018885 | 1.73 | 83.75 | Palliative (P) | 2020-11-01 | 2020-11-08 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101832521 |
| 160013737 | 160018886 | 1.69 | 73.5 | null | 2020-10-28 | 2020-11-08 | Trabectedin | 02 | null | TRABECTEDIN | 100389343 |
| 160013742 | 160018887 | 1.6 | 87 | Palliative (P) | 2021-10-08 | 2021-10-16 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100743894 |
| 160013768 | 160018889 | 1.81 | 80.3 | Palliative (P) | 2019-10-04 | 2020-10-08 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101493220 |
| 160013776 | 160018890 | 1.72 | 97 | Palliative (P) | 2021-10-04 | 2021-10-06 | Trabectedin | 02 | N | TRABECTEDIN | 100080136 |
| 160013782 | 160018891 | 1.75 | 90.8 | Palliative (P) | 2019-02-07 | 2019-03-02 | DOXORUBICIN | 02 | N | VINORELBINE | 100150842 |
| 160013784 | 160018892 | 1.85 | 111 | null | 2021-02-09 | 2021-02-13 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 101234502 |
| 160013785 | 160018893 | 1.59 | 90.55 | null | 2021-02-08 | 2021-07-28 | Trabectedin | 02 | null | TRABECTEDIN | 100750615 |
| 160013801 | 160018894 | 1.75 | 67.9 | Palliative (P) | 2019-07-30 | 2019-12-12 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100509946 |
| 160013809 | 160018895 | null | 81.6 | null | 2019-06-13 | 2019-07-06 | Vinorelbine (oral) | 02 | null | VINORELBINE | 100071353 |
| 160013818 | 160018896 | 1.59 | 68 | Palliative (P) | 2020-12-20 | 2021-02-19 | DOXORUBICIN | 02 | N | NIVOLUMAB | 100331245 |
| 160013826 | 160018897 | 1.83 | 59.9 | Palliative (P) | 2021-06-14 | 2021-06-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100112479 |
| 160013828 | 160018898 | 1.72 | 91.8 | null | 2021-12-12 | 2021-12-23 | DOXORUBICIN | 02 | null | VINORELBINE | 100122744 |
| 160013837 | 160018899 | 1.64 | 70 | null | 2020-08-16 | 2020-08-30 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101070988 |
| 160013847 | 160018900 | 1.75 | 52.4 | Palliative (P) | 2017-09-25 | 2018-08-11 | DOXORUBICIN | null | N | VINORELBINE | 100955049 |
| 160013859 | 160018901 | 1.63 | 64.5 | null | 2019-10-18 | 2019-11-22 | Doxorubicin 75mg/m2 | 02 | null | TRABECTEDIN | 100379628 |